Thermo Fisher Scientific has introduced the Thermo Scientific Cascadion SM Clinical Analyzer at the EuroMedLab 2017 in Greece this past June. The new machine combines the use of clinical analyzers and liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a selective and sensitive manner.
The fully automated analyzer has been designed for ease of use, eliminating the need for laboratory scientists to have specialized knowledge. The Scientific Cascadion SM Clincal Analyzer can be used in a variety of settings, including hospital laboratories, and will provide results for a range of clinical tests.
The Cascadion system comes complete with assay kits for standardized results and provides traceability to results in reagent lots. It is a turnkey solution that is quick and efficient, making this analyzer a potentially substantial development in clinical technology.
“Thermo Fisher is uniquely positioned to deliver an automated clinical analyzer that builds on our leading mass spectrometry platform,” commented Alan Sachs, chief scientific officer at Thermo Fisher Scientific. “It’s designed to provide clinical laboratories with a solution that is both efficient and effective in providing results for some of the most sought-after clinical tests. Cascadion has the potential to set new standards in the detection and measurement of specialty small molecule assays in the clinical lab.”
The equipment was designed and built using Thermo Fisher products and technologies and is waiting for regulatory approvals to become commercially available in Europe and the United States.